Neuroendocrine Cancer Clinical Trials

12 clinical trials for Neuroendocrine Cancer across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors — RECRUITING · PHASE1
• DLL3-Targeted PET/CT in Neuroendocrine Carcinoma — RECRUITING · NA
• Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer — RECRUITING · PHASE1
• Ivonescimab in the Treatment of Multiple Advanced Tumors — RECRUITING · PHASE2
• TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors — NOT_YET_RECRUITING · PHASE1
• AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer — NOT_YET_RECRUITING · PHASE2
• Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors — COMPLETED · PHASE2
• Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers — COMPLETED · PHASE2
• Clinical Trial of the Impact of Treatment Consultation Recordings on Cancer Patient Outcomes — COMPLETED · NA
• 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors — OTHER · PHASE1
• Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors — OTHER · PHASE2
• Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. — COMPLETED · PHASE1

Refine this search